Stress and Symptom Management Program 2 for Neurofibromatosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
NeurofibromatosisStress and Symptom Management Program 2 - Behavioral
Eligibility
12 - 17
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing two stress and symptom management programs for adolescents with Neurofibromatosis 1 and 2. The programs are 8 weeks long and done in a group setting.

Eligible Conditions
  • Neurofibromatosis

Treatment Effectiveness

Study Objectives

2 Primary · 6 Secondary · Reporting Duration: 0 weeks, 8 weeks, 6 months,12 months

Month 12
Anxiety
Depression
Environmental Quality of Life
Pain intensity
Pain interference
Month 12
Change in Physical Health Quality of Life
Change in Psychological Health Quality of Life
Social relationships Quality of Life

Trial Safety

Trial Design

2 Treatment Groups

Stress and Symptom Management Program 1
1 of 2
Stress and Symptom Management 2
1 of 2

Experimental Treatment

200 Total Participants · 2 Treatment Groups

Primary Treatment: Stress and Symptom Management Program 2 · No Placebo Group · N/A

Stress and Symptom Management Program 1
Behavioral
Experimental Group · 1 Intervention: Stress and Symptom Management Program 1 · Intervention Types: Behavioral
Stress and Symptom Management 2
Behavioral
Experimental Group · 1 Intervention: Stress and Symptom Management Program 2 · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 0 weeks, 8 weeks, 6 months,12 months

Who is running the clinical trial?

United States Department of DefenseFED
777 Previous Clinical Trials
202,297 Total Patients Enrolled
1 Trials studying Neurofibromatosis
19 Patients Enrolled for Neurofibromatosis
Massachusetts General HospitalLead Sponsor
2,699 Previous Clinical Trials
30,842,962 Total Patients Enrolled
2 Trials studying Neurofibromatosis
151 Patients Enrolled for Neurofibromatosis
Ana-Maria Vranceanu, PhDPrincipal Investigator - Massachusetts General Hospital
Massachusetts General Hospital
14 Previous Clinical Trials
1,418 Total Patients Enrolled
2 Trials studying Neurofibromatosis
151 Patients Enrolled for Neurofibromatosis

Eligibility Criteria

Age 12 - 17 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a diagnosis of NF1 or NF2 and are between the ages of 12-17.